Mohamed Benderdour

Mohamed Benderdour is a Full Professor in the Department of Surgery at the University of Montreal and a Regular researcher at the Research Center of the Sacré-Coeur Hospital of Montreal, where he contributes to the Trauma – acute care research axis. His academic career spans over two decades with significant contributions to biochemical research related to joint diseases.

Dr. Benderdour's research primarily focuses on the biochemistry of lipid peroxidation aldehydes and their implications in joint diseases, particularly osteoarthritis. His work investigates how aldehydes alter cellular metabolism and cause post-translational modifications of proteins, with specific attention to cell signaling mechanisms involving protein kinases and transcription factors. He has extensively studied 4-hydroxynonenal and its role in osteoarthritis pathogenesis, exploring mechanisms of gene regulation and promoter analysis in joint tissue pathology.

Analysis of Dr. Benderdour's publication history reveals an evolution from fundamental biochemical mechanisms to increasingly translational research. His recent work shows strong emphasis on RNA modifications in osteoarthritis (epitranscriptomics), nanotechnology approaches for therapeutic delivery (particularly chitosan-based nanovectors for siRNA), and the pathophysiology of immunoporosis. His publications demonstrate a progression toward developing therapeutic applications from basic science discoveries.

Dr. Benderdour maintains a productive research career with publications spanning molecular biology, biochemistry, rheumatology, and nanotechnology. His work bridges basic science with potential clinical applications in orthopedics and joint disease treatment, reflecting a commitment to advancing both scientific understanding and potential therapeutic interventions for osteoarthritis and related conditions.